Haleon's U.S. Growth Fueled by Restocking, Not Demand -- Market Talk

Dow Jones10-30

0957 GMT - Haleon's third-quarter U.S. sales growth was fueled by e-commerce players including Amazon expanding inventories rather than by stronger consumer demand, Barclays analysts write. Restocking is likely to ease in the fourth quarter, leading to a 1.2% dip in U.S. revenue that will cloud the U.K. consumer-health group's 2026 outlook, the analysts say. Increased competition in U.S. vitamins, minerals and supplements led to lower pricing, the analysts write. Oral health products grew 6.9%, missing the 8% consensus, with Aquafresh and denture care particularly soft, the analysts add. Shares rise 2.5% at 353.50 pence. (william.gray@wsj.com)

 

(END) Dow Jones Newswires

October 30, 2025 05:57 ET (09:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment